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The Psychotic Symptom Rating Scales (PSYRATS) is 
an instrument designed to quantify the severity of delu-
sions and hallucinations and is typically used in research 
studies and clinical settings focusing on people with psy-
chosis and schizophrenia. It is comprised of the auditory 
hallucinations (AHS) and delusions subscales (DS), but 
these subscales do not necessarily reflect the psychologi-
cal constructs causing intercorrelation between clusters of 
scale items. Identification of these constructs is important 
in some clinical and research contexts because item clus-
tering may be caused by underlying etiological processes 
of interest. Previous attempts to identify these constructs 
have produced conflicting results. In this study, we com-
piled PSYRATS data from 12 sites in 7 countries, com-
prising 711 participants for AHS and 520 for DS. We 
compared previously proposed and novel models of under-
lying constructs using structural equation modeling. For 
the AHS, a novel 4-dimensional model provided the best 
fit, with latent variables labeled Distress (negative con-
tent, distress, and control), Frequency (frequency, dura-
tion, and disruption), Attribution (location and origin of 
voices), and Loudness (loudness item only). For the DS, a 
2-dimensional solution was confirmed, with latent variables 
labeled Distress (amount/intensity) and Frequency (preoc-
cupation, conviction, and disruption). The within-AHS and 
within-DS dimension intercorrelations were higher than 
those between subscales, with the exception of the AHS 
and DS Distress dimensions, which produced a correlation 
that approached the range of the within-scale correlations. 
Recommendations are provided for integrating these under-
lying constructs into research and clinical applications of 
the PSYRATS.
Key words: psychosis/schizophrenia/hallucinations/
delusions/symptom rating scales/structural equation 
modeling/principal component analysis
Introduction
The Psychotic Symptom Rating Scales (PSYRATS) is an 
instrument developed for quantification of the multidi-
mensional features of the psychotic symptoms of halluci-
nations and delusions.1 It is often used in research settings 
focusing on people with schizophrenia and psychosis to 
gather additional information regarding hallucinations and 
delusions over and above that provided by a general symp-
tom rating interview, such as the Positive and Negative 
Syndrome Scale (PANSS)2 or the Scale for the Assessment 
of Positive Symptoms (SAPS).3 Increasingly, it has been 
used as an outcome measure in trials of psychological 
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therapy4,5 and for comparing individuals with psychotic 
experiences with and without a “need for care.”6–8 Some 
groups have also used the PSYRATS for quantifying hal-
lucinations and delusions in nonclinical samples although 
the PSYRATS items may not match their experiences par-
ticularly well.9 A number of other instruments are avail-
able for assessment of specific aspects of voices, such as the 
beliefs about and response to voices,10 power appraisals,11 
interpretation,12 acceptance,13 mindfulness,14 and relation-
ship with voices,15 but do not include phenomenological/
topographical aspects of voices such as frequency, loud-
ness, and location, and therefore may complement the 
PSYRATS but would not replace it.
The PSYRATS is comprised of 17 items inquir-
ing about the specific dimensions of hallucinations and 
delusions, with each item being rated from 0 (absent) to 
4 (severe). The PSYRATS has 2 subscales: the auditory 
hallucinations subscale (AHS) consisting of 11 items, and 
the delusions subscale (DS) consisting of 6 items. The 
AHS items are Frequency, Duration, Location, Loudness, 
Origin, Negativity (Amount/Degree), Distress (Amount/
Intensity), Disruption, and Controllability. The DS items 
are Preoccupation (Amount/Duration), Conviction, 
Distress (Amount/Intensity), and Disruption. Although 
the AHS and DS subscales have face validity, they do not 
necessarily reflect the psychological constructs underlying 
the scale. Identification of these constructs is important 
for many clinical and research contexts (eg, measuring 
change in cognitive/biological processes), because when 
certain PSYRATS items cluster together, that clustering 
may be caused by some underlying etiological process 
(eg, duration and disruption items on the AHS could all 
be affected by sustained hyperactivity in brain networks 
involving speech-related and auditory perception regions).
In several studies, patterns of intercorrelation between 
individual PSYRATS items have been analyzed in an 
exploratory fashion, and some encouraging consistencies 
have been observed. For example, for both the AHS and 
the DS, frequency-of-experience related items (eg, voices 
and/or thoughts are continuous) separated from distress-
related items in all studies.1,16–18 This suggests that separa-
ble phenomenological and etiological processes underlie 
duration and distress for both hallucinations and delu-
sions. In other words, although duration and distress 
may share some underlying etiological processes (ie, the 
dimensions may be correlated), they are measurably dis-
tinct in some way.1,16–18
Despite these consistencies in the published studies on 
the dimensional structure of the PSYRATS, a number 
of inconsistencies have also emerged. For example, the 
number of dimensions underlying the AHS have been 
proposed to be 3 (emotional, physical, and cognitive) in 
some studies (Drake et al16, N = 257; Haddock1, N = 71) 
but 4 (emotional, physical, control, and cognitive) in oth-
ers (Kronmuller et al17, N = 200; Steel et al18, N = 276). 
The major difference between the 3- and 4-dimensional 
solutions was that the 4-dimensional solution placed 
disruption/control and location/origin onto distinct 
dimensions (referred to as “control characteristics” and 
“cognitive interpretation,” respectively), whereas they 
were merged in the 3-dimensional solution (under “cog-
nitive interpretation”). With respect to the DS, all studies 
agreed on 2 underlying dimensions although disruption 
was placed with amount/duration of delusions in some 
studies 1,16,17 but with distress in another.18
These inconsistencies may have been caused by analysis 
of site-specific groups of patients because some samples 
were derived from research studies with specific inclusion 
and exclusion criteria.16,18 This may adversely affect gen-
eralizability to all patients with psychosis, as would other 
factors such as site-specific rater-training methods. To 
resolve these inconsistencies, a multisite data set is helpful 
because this serves to increase external validity and gen-
eralizability. In order to compare the competing models 
directly, confirmatory dimension reduction can be used. 
In this study, we compared the proposed dimensional 
structures of the PSYRATS using structural equation 
modeling (SEM) in an international multisite sample of 
patients with psychosis and schizophrenia and explored 
associations of each dimension with demographic vari-
ables. This work was undertaken as part of the activi-
ties of the 1st and 2nd International Consortium on 
Hallucination Research conferences in London and 
Durham, in 2011 and 2013.19,20
Methods
Participants
The numbers of participants in the final sample, along 
with total scores for the AHS and DS, are listed in table 1, 
columns 3–6. The group of Sommer et  al (Utrecht) is a 
University Medical Center, in which patients are interviewed 
for both clinical and research purposes. The Waters site 
(Perth) is a clinical research center attached to the University 
of Western Australia. The Badcock/Chhabra site (Perth) is 
a clinical research center; participants were tested as part 
of a doctoral research thesis (S.C.). The Bern group on hal-
lucination research (Hubl/Kindler/Homan) is a University 
Hospital with inpatient and outpatient treatment facilities, 
where all patients are assessed with the PSYRATS, and some 
participate in diverse research studies (eg, neuroimaging). 
The Allen/Mechelli (London) site recruited ultrahigh-risk 
for psychosis individuals from a specialist prodromal clinic 
(Outreach and support in South London), and the Peters/
Kuipers site (London) is a specialist psychological therapy 
service (Psychological Interventions Clinic for outpatients 
with Psychosis), both in the South London and Maudsley 
National Health Services Foundation Trust. The Lecomte 
site (Montreal) recruits individuals with early psychosis from 
2 first-episode programs who were participating in a study on 
group cognitive behavioral therapy (CBT) for psychosis. The 
Erickson site (Vancouver) is an early psychosis program and 
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the participants were enrolled in a study investigating the effi-
cacy of CBT. The Woodward site (Vancouver) is a research 
setting whereby all patients are participating in research 
studies on cognition and/or functional neuroimaging. Cella 
(Swansea) recruited participants from outpatient commu-
nity mental health services as part of a research project. The 
Siddi/Preti site (Cagliari) is a psychiatric service, where par-
ticipants were enrolled in a study investigating the neuropsy-
chological correlates of verbal auditory hallucinations. The 
Keedy site (Chicago) is a research laboratory in a university 
medical center setting whereby patients are participating in 
research studies on neurocognition with naturalistic observa-
tion of treatment changes.
The AHS data consisted of 711 patients who responded 
to all 11 items of the hallucination scale. Demographic 
variables (and the Ns on which they are based) were as fol-
lows: the mean age was 36.54 (SD = 10.86; N = 711), mean 
illness duration was 12.55 years (SD = 10.72; N = 407), 
and mean years of education was 11.89 (SD  =  3.13; 
N  =  392). The sample was 58.4% male (N  =  711), and 
91.4% were right handed (N = 394). Schizophrenia spec-
trum diagnoses were as follows, as specified by the diag-
nostic manuals (ie, DSM-IV or ICD-10) or according the 
procedures of the individual site: schizophrenia: 48.4%; 
schizoaffective: 5.8%; psychosis NOS: 9.0%; first-episode 
psychosis: 3.7%; at-risk mental state: 2.4%; and seeking 
treatment for psychosis: 30.8%.
The DS data consisted of 520 patients who responded to 
all 6 items of the delusions scale. Demographic variables 
(and the Ns on which they are based) were as follows: the 
mean age was 36.39 (SD = 10.5; N = 520), mean illness 
duration was 9.05 years (SD = 8.85; N = 230), and mean 
years of education was 12.22 (SD = 3.33; N = 213). The 
sample was 60.6% male (N = 520), and 93.8% were right 
handed (N = 161). Diagnosis information was as follows: 
schizophrenia: 31.5%; schizoaffective: 3.8%; psychosis 
NOS: 1.9%; first-episode psychosis: 5.0%; at-risk mental 
state: 3.8%; and seeking treatment for psychosis: 53.8%.
The AHS + DS data consisted of 325 patients who 
responded to both the 11 items of the AHS and 6 items 
of the DS scale. Demographic variables (and the Ns on 
which they are based) were as follows: the mean age was 
35.52 (SD = 10.63; N = 325), mean illness duration was 
8.48 (SD  =  9.01; N  =  170), and mean years of educa-
tion was 11.85 (SD  =  3.48; N  =  153). The sample was 
59.4% male (N = 325), and 97.1% were right handed (N = 
104). Diagnosis information was as follows: schizophre-
nia: 34.5%; schizoaffective: 5.5%; psychosis NOS: 2.2%; 
first-episode psychosis: 8.0%; at-risk mental state: 4.9%; 
seeking treatment for psychosis: 44.9%.
Sample size, age, duration of illness, and mean subscale 
score are presented as a function of site in table 1 col-
umns 3–6 for AHS, columns 7–10 for DS, and columns 
11–14 for AHS + DS.
Data Analysis Strategy
Structural Equation Modeling. For SEM, we used 
Generalized Structured Component Analysis (GSCA).21 
GSCA is a component-based method of SEM, which 
approximates a latent variable as a component or weighted 
composite of observed variables (as in principal component 
analysis [PCA]). Thus, GSCA allows direct computation of 
latent variable scores.22 Latent variable scores provide one 
value per participant, specifying the strength of each symp-
tom dimension for that participant. Latent variable scores, 
as with PCA, can be used to associate symptom dimensions 
with demographic variables such as gender and length of ill-
ness.23,24 Using GSCA, individual latent variable scores can 
be directly and uniquely computed and are optimized to 
Table 1. Sample Size, Mean Age, Mean Duration of Illness, and Mean Subscale Score as a Function of Site
Site
Testing 
Location AHS (N) Age DI
AHS 
Total DS (N) Age DI DS Total
AHS + 
DS (N) Age DI
AHS + 
DS Total
1 Utrecht 208 35.76 15.63 29.72 n/a n/a n/a n/a n/a n/a n/a n/a
2 Perth 32 36.38 13.94 24.63 n/a n/a n/a n/a n/a n/a n/a n/a
3 Perth 32 40.63 18.13 26.59 n/a n/a n/a n/a n/a n/a n/a n/a
4 Bern 54 39.57 13.04 24.46 54 39.57 13.04 8.81 54 39.57 13.04 33.28
5 London 43 24.35 0.51 12.19 46 24.41 0.61 9.57 42 24.45 0.61 22.00
6 Montreal 31 23.71 3.41 11.48 29 26.93 3.97 8.38 26 26.69 3.97 17.62
7 Vancouver 15 23.80 2.50 15.40 16 24.06 2.41 8.94 15 23.80 2.41 24.93
8 London 219 39.92 n/a 26.91 280 39.53 n/a 15.04 146 39.38 n/a 41.71
9 Vancouver 10 37.90 17.10 28.10 61 31.79 12.99 12.40 8 37.25 12.99 38.44
10 Swansea 34 37.74 15.91 17.21 34 37.74 15.91 7.97 34 37.74 15.91 25.18
11 Cagliari 18 37.67 10.56 25.61 n/a n/a n/a n/a n/a n/a n/a n/a
12 Chicago 15 42.87 20.07 26.80 n/a n/a n/a n/a n/a n/a n/a n/a
Ns 711 711 407 711 520 520 230 520 325 325 170 325
Note: Site: 1. Daalman/Sommer/van Lutterveld; 2. Waters/Badcock/Maybery; 3. Badcock/Chhabra; 4. Hubl/Kindler/Homan; 5. Allen/
Mechelli; 6. Lecomte; 7. Erickson; 8. Peters/Kuipers; 9. Woodward; 10. Cella; 11. Siddi/Preti; 12. Keedy. AHS = Auditory Hallucinations 
Scale; DS = Delusions Scale. n/a = not available. Total score is computed by summing all items on the respective scales. DI = Duration of 
Illness.
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explain the maximum proportion of variance in PSYRATS 
items. Unlike with GSCA, in factor-based SEM,25,26 a latent 
variable is approximated as a common factor. Accordingly, 
individual latent variable scores are not unique, such that 
different scores can lead to the same model fit, known as 
factor score indeterminacy.27 GSCA latent variable scores 
are computed by postmultiplying the corresponding origi-
nal item scores by weight estimates.21 These individual 
scores can then be related to demographic variables using 
standard analysis procedures.24
In addition to direct computation of latent variable 
scores, component-based SEM has 2 additional advan-
tages over factor-based SEM. First, it is more flexible with 
respect to model specification, and accordingly, GSCA 
almost never encounters problems of nonconvergence, or 
convergence to improper solutions (eg, negative variance 
estimates), a condition frequently affecting covariance-
based methods.27 Second, GSCA does not rely on strin-
gent distributional assumptions, such as the multivariate 
normality of observed variables, an assumption that is 
likely violated in PSYRATS data due to some items con-
sisting of a disproportionate number of low scores. Thus, 
GSCA is considered beneficial due to direct computa-
tion of latent variable scores, and application to complex 
models and/or data sets with high potential for multivari-
ate nonnormality. For these reasons, GSCA was used to 
compute latent variable scores optimized to explain the 
maximum proportion of variance in PSYRATS items 
according to the investigated models.
Hallucinations Scale
Models
Several investigations have explored the dimensional 
structure of the AHS using exploratory factor analy-
sis.1,16–18 These studies suggested either a 3-dimensional 
model, consisting of emotional characteristics, physi-
cal characteristics, and cognitive interpretation,1,16 or a 
4-dimensional model consisting of emotional character-
istics, physical characteristics, control characteristics, and 
cognitive interpretation.17,18 In this study, we evaluated 
how well these models fit the data, and a third (novel) 
model was also developed using exploratory PCA. In 
order to use exploratory PCA to develop a novel model, 
care must be taken to avoid circular reasoning. Specifically, 
if  exploratory PCA were carried out on the full data set 
and GSCA FIT values for that model were compared to 
competing models from the literature on the same data 
set, the exploratory PCA-derived model would provide 
the best fit because it was derived from the same data on 
which it was tested. To avoid this circularity, split-half  
methodology was used. This involves randomly splitting 
the data set into 2 halves, deriving the exploratory PCA 
model on the first half  of the data but comparing the fit 
of the exploratory model to that of the competing mod-
els from the literature on the preserved half  of the data. 
For this study, if  the novel exploratory PCA model pro-
duced FIT values on the preserved half  of the data that 
were superior to those from past work, this model could 
then be considered preferable to the other models.
To evaluate the models statistically, overall goodness-
of-fit measures, named FIT in GSCA, were compared, 
with higher relative FIT values indicating superior model 
fit.21 FIT values can be interpreted as the percentage of 
variance in the PSYRATS items accounted for by the 
model.21 Differences between FIT statistics for competing 
models were tested for significance using bootstrapping.28 
Specifically, we fitted 2 models to each of n bootstrap sam-
ples (n = 100 in this study), which were randomly drawn 
from the original data set with replacement, and calculated 
the differences of FIT values computed on the 2 models. 
Following this, we applied a 1-sample t-test to the differ-
ence scores, using degrees of freedom equal to n = 1 (99 
in this case). If  the mean of the difference scores was not 
statistically different from zero, this would indicate that 
there is no reliable mean difference in FIT between the 2 
models. This methodology can result in significant (and 
reliable) differences between FIT values that differ by only 
a few percentage points. Thus, differences in these FIT sta-
tistics cannot be interpreted in the same fashion as differ-
ences between correlations coefficients computed on one 
sample,29 which typically require a substantial gap in val-
ues to be considered reliably different. As for all SEM fit 
statistics, it is currently not known how differences in FIT 
statistics translate into practical differences in subscale 
computation applications and effect sizes. In this study, 
we simply conclude that model A would be preferred over 
model B if  the FIT value for model A is reliably (ie, signifi-
cantly) higher than that for model B, with the real-world 
impact of that FIT difference being currently unknown.
Results
The loadings for the 3- and 4-dimensional models esti-
mated by GSCA are provided in table 2. In both, all items 
loaded significantly onto their respective latent variables, 
indicating that the latent variables were well constructed. 
GSCA indicated that the FIT value of the 3-dimensional 
model was 0.520, such that 52% of the total variance of 
all observed PSYRATS items was accounted for by the 
specified latent variables. FIT for the 4-dimensional model 
was 0.531, such that 53.1% of the total variance of all 
observed PSYRATS items was accounted for by the speci-
fied latent variables. The bootstrapped t-test between the 
3- and 4-dimensional models was significant, t(99) = 5.90, 
P < .001, indicating that there is a reliable mean differ-
ence in FIT between the 2 models, justifying choice of the 
4-dimensional model over the 3-dimensional model.
We also tested the fit of a novel model based on explo-
ration of the current data set. We randomly split the 
data into 2 halves and carried out a pseudo-exploratory 
PCA on 1 half (whereby the analysis was restricted to 
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4 components, as was suggested by model fits reported 
above). This resulted in a novel (4-dimensional) model 
that was characterized by the Cognitive (COG) dimension 
from the original 4-dimensional model, the Physical (PHY) 
dimension from the original 4-dimensional model with 
Disruption added, and the Emotional (EMO) dimension 
from the 3- and 4-dimensional models with the Control 
item added. Loudness (LDN) remained independent from 
all other dimensions and was derived from the Control/
Loudness (CON) dimension from the original 4-dimen-
sional model (Disruption and Control moved to PHY and 
EMO, respectively, thereby dismantling the CON dimen-
sion). We then compared the 3- and 4-dimensional models 
with the new exploratory model on the preserved half of 
the data set. For this analysis, we found that, as with the 
full data set, the 3-dimensional model provided the poor-
est FIT (0.522), and the 4-dimensional and new explor-
atory models provided substantially better FIT (0.530 
and 0.543, respectively). To statistically compare the FIT 
values of these 3 models using bootstrapping, a 1-way 
ANOVA was carried out with 1 between-subjects factor 
with 3 levels (the 3 models), and this was highly signifi-
cant, F(2, 297) = 72.83, P < .001. This was followed up 
by a Scheffe’s test to examine which models were different 
from one another. The results of the multiple comparisons 
test suggested that, as above, the 4-dimensional model 
FIT was superior to the 3-dimensional model (mean dif-
ference = −0.0064; 95% CI = −0.0107, P < .005) and that 
the new exploratory model FIT was superior to the 3- and 
4-dimensional model (mean difference from the 4-dimen-
sional model = −0.0142; 95% CI = −0.0185, P < .001).
Delusions Scale
Models
Previous investigations into the dimensional structure 
of the DS using exploratory factor analysis suggested 
2-dimensional models with different configurations of 
items, labeled COG and EMO.1,16–18 One model placed 
Disruption with Amount/Duration,1,16,17 and the con-
trasting model placed Disruption with Distress.18 These 
2 models are contrasted here using SEM. An exploratory 
PCA analysis on the full data set did not produce a novel 
model over and above these 2, so the split-half  methodol-
ogy used with the AHS reported above was not necessary.
Results 
The loadings for the disruption-with-duration and dis-
ruption-with-distress models estimated by GSCA are 
provided in table 3. In both models, all items loaded sig-
nificantly onto their respective latent variables. GSCA 
indicated a FIT value of 0.563 for the disruption-with-
duration model and 0.558 for the disruption-with-dis-
tress model. The bootstrapped t-test comparing the 
models was significant, t(99)  =  5.06, P < .001, indicat-
ing that disruption-with-duration could be chosen over 
disruption-with-distress.
Hallucinations and Delusions Scales
Models
In the previous set of  analyses, we concluded that a novel 
4-dimensional model was optimal for AHS and that the 
2-dimensional disruption-with-duration model was opti-
mal for DS. We now investigate the dimensional struc-
ture of  PSYRATS as a whole, ie, a 6-dimensional model 
of  PSYRATS based on the subsamples of  the AHS and 
DS, who completed both scales. We did not use the split-
half  exploratory analyses methodology on these data 
because the sample size of  the AHS + DS data set was 
the smallest of  the 3. We instead preserved the optimal 
dimension structure derived from the full AHS and DS 
samples.
Table 2. Auditory Hallucinations Scale Model Loadings
Item
3-Dimension Model  
FIT = 0.520
4-Dimension Model  
FIT = 0.531
Exploratory Model  
FIT = 0.541
Label Loading Label Loading Label Loading
6 Negative content amount EMO 0.91 EMO 0.91 EMO 0.89
7 Negative content degree 0.87 0.87 0.85
8 Distress amount 0.91 0.91 0.90
9 Distress intensity 0.88 0.88 0.88
1 Frequency PHY 0.83 PHY 0.90 PHY 0.88
2 Duration 0.88 0.90 0.84
4 Loudness 0.71 CON 0.68 LDN 1.00
10 Disruption COG 0.74 0.80 PHY 0.82
11 Control 0.77 0.81 EMO 0.68
3 Location 0.69 COG 0.83 COG 0.83
5 (Beliefs regarding) origin 0.73 0.84 0.84
Note: EMO, motional, PHY, physical, COG, cognitive; CON, control; LDN, loudness. All loadings were significant at P < .05. FIT value 
for full AHS sample is reported (N = 711).
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Results
The loadings for the 6-dimensional model of AHS and DS 
are provided in table 4, along with Intraclass Correlation 
Coefficients (ICC), which provide estimates of reliability 
for each subscale.30 All items loaded significantly onto 
their respective latent variables, and GSCA indicated that 
the FIT value was 0.558.
Labeling Dimensions. In order to better reflect the paral-
lels between the AHS and DS dimensions and to sharpen 
the concepts conveyed by the dimensional structure, we 
generated new labels for the dimensions. The H-EMO and 
D-EMO items were commonly renamed Distress (H-DIS 
and D-DIS, respectively), to highlight the fact that 
although emotion-related symptoms (ie, negative content) 
are not captured by the DS, distress-related symptoms 
are, making the AHS and DS parallel with respect to dis-
tress but not emotion. The H-PHY and D-COG dimen-
sions were commonly renamed Frequency (H-FRQ and 
D-FRQ, respectively) to emphasize that frequency-of-
occurrence items formed the basis of both dimensions. 
Notably, both the H-FRQ and the D-FRQ scales included 
the Disruption item. The H-COG dimension was renamed 
Attribution (H-ATT) to emphasize the involvement of 
items indexing the internal/external attribution of loca-
tion and source. H-LDN remained unchanged.
Correlations Among Dimensions. The correlations 
among the 6 latent variables are presented in table 5 and 
indicate that the AHS dimensions and the DS dimensions 
were highly correlated within each scale but that the cor-
relations between scales were reduced, with the H-DIS 
Table 3. Delusion Scale Model Loadings
Item
Disruption-With-Distress 
FIT = 0.558
Disruption-With-Duration 
FIT = 0.563
Dimension Loading Dimension Loading
1 Preoccupation amount COG 0.87 COG 0.85
2 Preoccupation duration 0.90 0.88
3 Conviction 0.82 0.80
4 Disruption EMO 0.75 0.75
5 Distress amount 0.90 EMO 0.95
6 Distress Intensity 0.92 0.95
Note: COG, cognitive; EMO, emotional. All loadings were significant at P < .05.
Table 4. Full 6-Dimensional Model Loadings
Old Label New Label ICC Item Loading
H-EMO H-DIS .93 6 Negative content amount 0.89
7 Negative content degree 0.85
8 Distress amount 0.90
9 Distress intensity 0.88
11 Control 0.68
H-PHY H-FRQ .87 1 Frequency 0.88
2 Duration 0.84
10 Disruption 0.82
H-COG H-ATT .67 3 Location 0.83
5 (Beliefs regarding) origin 0.84
H-LDN H-LDN n/a 4 Loudness 1.00
D-EMO D-DIS .93 4 Distress amount 0.95
5 Distress intensity 0.95
D-COG D-FRQ .87 1 Preoccupation amount 0.85
2 Preoccupation duration 0.88
3 Conviction 0.80
6 Disruption 0.75
Note: H- denotes auditory hallucination scale and D- denotes delusion scale. DIS, distress; FRQ, frequency; ATT, attribution; LDN, 
loudness; ICC, intraclass correlation; n/a, not applicable. Coefficient (ICC) estimate of reliability. All loadings were significant at P < .05, 
FIT = 0.558.
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and D-DIS dimensions producing the highest cross-scale 
correlation. Statistical comparison of these correlations31 
demonstrated that the highest cross-scale correlation 
(0.47 between the H-DIS and D-DIS dimensions) did not 
differ significantly from the lowest within-scale correla-
tion (0.55 between H-FRQ and H-LDN), suggesting that 
this 1 cross-scale correlation involving distress was not 
reliably different from the lower range of the within-scale 
correlations. In contrast, the lowest within-scale correla-
tion (0.55 between H-FRQ and H-LDN) was significantly 
higher than all the remaining cross-scale correlations (ie, 
those other than the H-DIS and D-DIS correlation dis-
cussed above), ranging in magnitude from 0.21 to 0.38 
(all Ps < .005).
Relationships to Demographic Variables. Correlations 
of latent variable scores with available demographic vari-
ables were computed using the largest available samples. 
Age was not included in this analysis because it is highly 
confounded with length of illness (and site), and diag-
nosis was not included due to the wide range of labels 
used across sites (eg, first episode, psychosis NOS, at-
risk mental state, and seeking treatment for psychosis). 
Computed on the AHS full sample (N  =  711), H-DIS 
and H-LDN significantly differed between males and 
females, t(709) = 2.91, P < .005, t(709) = 4.78, P < .001, 
respectively, as females (M = .13, M = .21, respectively) 
had higher latent variables scores than males (M = −.09, 
M = −.15, respectively). For the DS full sample (N = 520), 
D-DIS significantly differed between males and females 
t(518)  =  2.64, P < .01, with females (M =.14) having 
higher latent variables scores than males (M  =  -.09). 
These results suggested that women report more distress 
in their hallucinations and delusions, as well as louder 
hallucinations, relative to men.
There was also evidence that scores on all aspects of 
hallucinations, but not delusions, increased with length 
of illness. Computed on the AHS full sample (N = 407 
with length of illness information), all latent variables 
were significantly and positively correlated with length 
of illness (r = .20, .19, .19 and .25 with H-DIS, H-FRQ, 
H-ATT, and H-LDN, respectively, all Ps < .05). No cor-
relations were significant for the DS latent variable scores. 
However, length of illness (and the related age variable) 
was strongly confounded with site, and AHS total score 
differed between sites (see table 1). Therefore, conclusions 
regarding length of illness must be considered highly ten-
tative because they may also be attributed to age and/
or site. Parallel association analyses computed on the 
smaller AHS + DS sample (N  =  325) gave essentially 
identical results, so are not reported here. There were no 
significant associations between the latent variable scores 
and handedness or education.
Discussion
In this study, PSYRATS models previously identified in 
the literature, and a novel model derived from the cur-
rent data, were empirically compared using SEM. For 
the AHS, a 4-dimensional model provided the best fit, 
with dimensions labeled DIS (Distress/Negative Content/
Control), FRQ (Frequency/Duration/Disruption), ATT 
(Attribution of voices: Location and Origin), and LDN 
(Loudness item only). For the DS, a 2-dimensional 
solution was confirmed, with DIS (Distress) and FRQ 
(Preoccupation, Conviction, and Disruption) emerging. 
A  model including both the AHS and DS dimensions 
showed higher latent variable score correlations within 
the AHS and DS scales than between, with the exception 
of the H-DIS and D-DIS dimensions, which produced a 
between-scale correlation that could be considered within 
the range of the high within-scale correlations. This pro-
vides the most definitive analyses of the factor structure 
of the PSYRATS to date because it involves the largest 
sample size, has the most representative patients (across 
research and clinical settings and across countries), and 
makes an empirical comparison of competing models 
using confirmatory methods (viz., SEM).
The fact that these sets of PSYRATS items cluster 
together can lead to identification of underlying etiologi-
cal processes. For example, the preoccupation, convic-
tion and disruption items on the DS could all be affected 
by a cognitive bias such as a bias against disconfirma-
tory evidence32 or jumping to conclusions bias (JTC),33,34 
contributing to the formation of the D-FRQ dimension. 
Similarly, the frequency, duration, and disruption items 
Table 5. The Coefficients Obtained From the 6-Dimensional Model
H-DIS H-FRQ H-ATT H-LDN D-DIS D-FRQ
H-DIS 1.00
H-FRQ 0.77 1.00
H-ATT 0.66 0.66 1.00
H-LDN 0.61 0.55 0.58 1.00
D-DIS 0.47 0.31 0.36 0.28 1.00
D-FRQ 0.37 0.32 0.38 0.21 0.76 1.00
Note: H- denotes auditory hallucination scale and D- denotes delusion scale. DIS, distress; FRQ, frequency; LDN, loudness; ATT, 
attribution. All correlation coefficients were significant at P < .05.
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on the AHS could all be affected by sustained hyperactiv-
ity in brain networks involving speech-related and audi-
tory perception regions,35,36 contributing to the formation 
of the H-FRQ dimension. For practical application of 
these results (eg, computation of an outcome measure), 
summation of items can be used in place of computation 
of latent variable scores. The recommended procedure 
for all dimensions is to sum the specific items compris-
ing each of the H-DIS, H-FRQ, H-ATT, H-LDN (only 
one item), D-FRQ, and D-DIS dimensions (as listed in 
table 4). For example, the H-FRQ dimension would be 
computed by simply summing the Frequency, Duration, 
Disruption items on the AHS.
The differentiation of separate constructs within the 
AHS and DS may be important for the study of etio-
logical processes involved in psychosis, such as change 
in symptoms and their underlying brain networks in 
response to treatment. Treatment approaches may rea-
sonably target certain dimensions, such as distress,18 and 
these dimension may relate to cognitive biases underlying 
delusions in different ways. For example, 1 study using 
the 3-dimensional solution found that COG and EMO 
were related to cognitive biases in healthy and clinical 
samples of people experiencing hallucinations, but PHY 
was not.7 In another study,37 different dimensions of 
delusions changed at different rates over time in response 
to medication, and the JTC bias predicted treatment 
response on some dimensions but not others. In another 
article in this special issue,38 it is argued that CBT for psy-
chosis trials have not used optimal outcome measures to 
assess change because CBT aims to reduce distress and 
disruption and not change physical characteristics of 
voices. Thus, the dimensions likely to change with a given 
intervention may vary, and the primary outcome measure 
should be specified depending on the goal of the study. 
However, it should be noted that some CBT for psychosis 
protocols specifically target disruption due to voices but 
not their frequency.39,40 In this case, the use of individual 
items on the PSYRATS may be more sensitive to change 
than using the H-FRQ dimension, which combines fre-
quency and disruption. Dimension reduction methods 
such as PCA and GSCA focus on the common variance 
between test items, but the item specific variance may also 
be important to capture under some conditions.
The current results also suggest that treatments reduc-
ing frequency and duration of voices would be most likely 
to also reduce disruption of daily life (H-FRQ includes 
Frequency, Duration and Disruption) and that voices 
with negative content (eg, threatening voices) are the 
most distressing and difficult to control (H-DIS includes 
Negative Content, Distress, and Control). Accordingly, 
research has shown that negative content can distinguish 
clinical voice-hearers from nonclinical ones (see another 
article in this special issue).8 However, it should be noted 
that these results do not imply that negative content can 
be equated to distress,41 only that negative content and 
distress tend to co-occur and that these items would be 
expected to correlate in data samples.
The H-ATT dimension may be of  particular interest, 
as it includes the (Beliefs About) Origin item, and the 
variance that it shares with Location. Beliefs and expe-
riences regarding the originating source of  the voices 
appears to tap into the personal meaning attributed 
to these experiences more than any other PSYRATS 
item. This refers to a common frame of  reference for 
voice-hearing experiences, mainly internal (cognitive/
biological explanation) or external (mystical or divine 
explanation), a key concept to the Hearing Voices 
Movement (HVM), which is discussed in another article 
in this special issue.42 The HVM suggests that an effec-
tive practice for supporting distressed individuals with 
hallucinations should involve trying to understand such 
a frame of  reference, and supporting a change in the 
person’s relationship with their voices with an explora-
tion of  who/what the voices represent. The reframing 
of  appraisals is also a key focus for many psychologi-
cal therapies, which hold that a change in the personal 
meaning assigned to the voice can lead to better coping 
and reduced intensity/distress.43,44
GSCA was selected for this analysis partly because 
it allows direct computation of latent variable scores, 
allowing observation of intercorrelations of the AHS 
and DS scales. This led to the observation that the within-
AHS-scale and within-DS-scale dimension correlations 
were higher than those between, with the exception of 
the hallucinations and delusions dimensions indexing 
distress (H-DIS and D-DIS), which produced a correla-
tion not reliably different from the range of the within-
scale correlations. This correlation may be attributable to 
the distressing aspects of highly negative voices leading 
to distressing (eg, paranoid) delusions. Correlation of 
latent variable scores with demographic variables led to 
the observation that the hallucination dimension index-
ing distress and emotional content (H-DIS) was higher 
in women than men and that hallucinations were rated 
as louder in women relative to men. Although it has pre-
viously been reported that hallucinations (and not delu-
sions) are more common in women than men,45 to our 
knowledge, this is the first study reporting sex differences 
in severity of specific aspects of hallucinatinos. Finally, 
scores on all aspects of hallucinations, but not delusions, 
increased with length of illness although this effect was 
highly confounded with age and site, whereby some sites 
focused on patients in the very early stages of their illness 
(see table 1). The confounding nature of age, length of 
illness, and site in this sample made the length of illness 
finding very difficult to interpret and therefore this result 
must be considered highly tentative.
An important caveat of this work is that it is not 
known whether the identified dimensions exhaustively 
represent all relevant dimensions of hallucinations and 
delusions because these were derived from PSYRATS 
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items, which were selected based on interviews with hal-
lucinating patients.1(p881) Also, other more general scales 
(eg, PANSS) were not readily available for investigations 
of PSYRATS external validity because a range of gen-
eral scales were used at the different sites.
The PSYRATS provides quantification of  phenom-
enological/topographical aspects of  voices, such as fre-
quency, loudness, and location, that are not available 
with other scales and also provides a more detailed 
assessment of  delusions than is typically available with 
more general scales. Our results suggest that clinical and 
research use of  the PSYRATS (eg, to evaluate symp-
tom change) could benefit from computation of  the 6 
subscales listed in table  4, involving summing the spe-
cific items comprising each of  the dimensions. The loud-
ness item would simply be left as an individual item. 
This methodology could potentially allow clinicians and 
researchers to discriminate finer aspects of  change in 
hallucinations or delusions and provides methodology 
for identifying more homogenous subgroups of  partici-
pants with auditory hallucinations or delusions. As men-
tioned above, this can aid in the search for underlying 
etiological processes. Future studies may investigate how 
the dimensions of  the PSYRATS are associated with 
other more general scales such as the PANSS46 or SAPS,3 
or with other specific aspects of  psychotic symptoms, 
such as omnipotence of  beliefs about hallucinations,10 or 
mindful response.47
Funding
Canadian Institutes of Health Research and the Michael 
Smith Foundation for Health Research (to T.S.W.); British 
Columbia Schizophrenia Society Foundation and Mitacs 
Elevate (to K.J.); United States National Institute of 
Mental Health award (K23MH092702 to S.K.); Regione 
Sardegna, Italy (PRR-MAB-A2011-19251 to S.S.).
Acknowledgments
F.W., S.C., and J.B. would like to acknowledge training, 
infrastructure, and administrative support from Winthrop 
Professor Assen Jablensky (Director) Centre for Clinical 
Research in Neuropsychiatry, School of Psychiatry and 
Clinical Neuroscience, University of Western Australia; 
and the Clinical Research Centre, North Metropolitan 
Health Service-Mental Health, Perth, Western Australia. 
E.P., E.K., P.A.  and M.C.  wish to acknowledge the 
National Institute for Health Research Biomedical 
Research Centre for Mental Health at South London 
and Maudsley NHS Foundation Trust and (Institute of 
Psychiatry) King’s College London. P.A. and A.M. thank 
William Pettersson-Yeo and Stefania Benetti for data col-
lection. The authors have declared that there are no con-
flicts of interest in relation to the subject of this study.
References
 1. Haddock G, McCarron J, Tarrier N, Faragher EB. Scales 
to measure dimensions of hallucinations and delusions: the 
psychotic symptom rating scales (PSYRATS). Psychol Med. 
1999;29:879–889.
 2. Kay SR, Opler LA, Lindenmayer JP. The Positive and 
Negative Syndrome Scale (PANSS): rationale and standardi-
sation. Br J Psychiatry Supplement. 1989;155:59–67.
 3. Andreasen NC. The Scale for the Assessment of Positive 
Symptoms (SAPS). Iowa City, IA: The University of Iowa 
Press; 1984.
 4. Garety PA, Fowler DG, Freeman D, Bebbington P, Dunn G, 
Kuipers E. Cognitive–behavioural therapy and family interven-
tion for relapse prevention and symptom reduction in psychosis: 
randomised controlled trial. Br J Psychiatry. 2008;192:412–423.
 5. Lewis S, Tarrier N, Haddock G, et al. Randomised controlled 
trial of cognitive-behavioural therapy in early schizophrenia: 
acute-phase outcomes. Br J Psychiatry Suppl. 2002;43:s91–s97.
 6. Daalman K, Boks MP, Diederen KM, et al. The same or dif-
ferent? A phenomenological comparison of auditory verbal 
hallucinations in healthy and psychotic individuals. J Clin 
Psychiatry. 2011;72:320–325.
 7. Daalman K, Sommer IE, Derks EM, Peters ER. Cognitive 
biases and auditory verbal hallucinations in healthy and clini-
cal individuals. Psychol Med. 2013;43:2339–2347.
 8. Johns LC, Kompus K, Connell M, et  al. Auditory verbal 
hallucinations in persons with and without a need for care. 
Schizophr Bull. 2014;40:S255–S264.
 9. Sommer IE, Daalman K, Rietkerk T, et  al. Healthy indi-
viduals with auditory verbal hallucinations; who are they? 
Psychiatric assessments of a selected sample of 103 subjects. 
Schizophr Bull. 2010;36:633–641.
 10. Chandwick P, Lees S, Birchwood M. The revised Beliefs 
About Voices Questionnaire (BAVQ-R). Br J Psychiatry. 
2000;177:229–232.
 11. Birchwood M, Meaden A, Trower P, Gilbert P, Plaistow J. 
The power and omnipotence of voices: subordination and 
entrapment by voices and significant others. Psychol Med. 
2000;30:337–344.
 12. Morrison AP, Wells A, Nothard S. Cognitive and emotional 
predictors of predisposition to hallucinations in non-patients. 
Br J Clin Psychol. 2002;41:259–270.
 13. Shawyer F, Ratcliff  K, Mackinnon A, Farhall J, Hayes SC, 
Copolov D. The voices acceptance and action scale (VAAS): 
Pilot data. J Clin Psychol. 2007;63:593–606.
 14. Chadwick PDJ, Barnbrook E, Newman-Taylor K. 
Responding mindfully to distressing voices: links with mean-
ing, affect and relationship with voice. J Norwegian Psychol 
Assn. 2007;44:581–588.
 15. Hayward M, Denney J, Vaughan S, Fowler D. The voice and 
you: development and psychometric evaluation of a meas-
ure of relationships with voices. Clin Psychol Psychother. 
2008;15:45–52.
 16. Drake R, Haddock G, Tarrier N, Bentall R, Lewis S. The 
Psychotic Symptom Rating Scales (PSYRATS): their useful-
ness and properties in first episode psychosis. Schizophr Res. 
2007;89:119–122.
 17. Kronmüller KT, von Bock A, Grupe S, et al. Psychometric 
evaluation of the Psychotic Symptom Rating Scales. Compr 
Psychiatry. 2011;52:102–108.
 18. Steel C, Garety PA, Freeman D, et al. The multidimensional 
measurement of the positive symptoms of psychosis. Int J 
Methods Psychiatr Res. 2007;16:88–96.
 at W
orld Trade Institute on D
ecem
ber 18, 2014
http://schizophreniabulletin.oxfordjournals.org/
D
ow
nloaded from
 
S274
T. S. Woodward et al
 19. Waters F. Multidisciplinary approaches to understanding 
auditory hallucinations in schizophrenia and nonschizo-
phrenia populations: the International Consortium on 
Hallucination Research. Schizophr Bull. 2012;38:693–694.
 20. Waters F, Woods A, Fernyhough C. Report on the 2nd 
International Consortium on Hallucination Research 
(ICHR): evolving directions and top 10 ‘hot spot’ in halluci-
nation research. Schizophr Bull. 2014;40:24–27.
 21. Hwang H, Takane Y. Generalized structured component 
analysis. Psychometrika. 2004;69:81–99.
 22. Tenenhaus M. Component-based structural equation model-
ling. Total Qual Manag Bus. 2008;19:871–886.
 23. Liddle PF, Ngan ET, Duffield G, Kho K, Warren AJ. Signs 
and Symptoms of Psychotic Illness (SSPI): a rating scale. Br 
J Psychiatry. 2002;180:45–50.
 24. Woodward TS, Jung K, Smith G, et  al. Symptom changes in 
five dimensions of the positive and negative syndrome scales 
in refractory psychosis. Eur Arch Psy Clin Neurosci. 2013; 
doi:10.1007/s00406-013-0460-x 
 25. Jöreskog KG. A general method for analysis of covariance 
structures. Biometrika. 1970;57:239–251.
 26. MacCallum RC, Austin JT. Applications of structural equa-
tion modeling in psychological research. Annu Rev Psychol. 
2000;51:201–226.
 27. Hwang H, Malhotra NK, Kim Y, Tomiuk MA, Hong 
S. A comparative study on parameter recovery of three 
approaches to structural equation modeling. J Market Res. 
2010;47:699–712.
 28. Efron B. Nonparametric estimates of standard error: the 
jackknife, the bootstrap and other methods. Biometrika. 
1981;68:589–599.
 29. Meng X, Rosenthal R, Rubin DB. Comparing correlated cor-
relation coefficients. Psychol Bull. 1992;111:172–175.
 30. McGraw KO, Wong SP. Forming inferences about some intra-
class correlation coefficients. Psychol Methods. 1996;1:30–46.
 31. Raghunathan TE, Rosenthal R, Rubin DB. Comparing cor-
related but nonoverlapping correlations. Psychol Methods. 
1996;1:178–183.
 32. Woodward TS, Moritz S, Cuttler C, Whitman JC. The con-
tribution of a cognitive bias against disconfirmatory evi-
dence (BADE) to delusions in schizophrenia. J Clin Exp 
Neuropsychol. 2006;28:605–617.
 33. Speechley WJ, Whitman JC, Woodward TS. The contribution 
of hypersalience to the “jumping to conclusions” bias associ-
ated with delusions in schizophrenia. J Psychiatry Neurosci. 
2010;35:7–17.
 34. Garety PA, Freeman D. Cognitive approaches to delusions: 
a critical review of theories and evidence. Br J Clin Psychol. 
1999;38(pt 2):113–154.
 35. Lavinge KM, Rapin LA, Metzak PD, et  al. Left-dominant 
temporal-frontal hypercoupling in schizophrenia patients 
with hallucinations during speech perception. Schizophr Bull. 
2014. doi:10.1093/schbul/sbu004
 36. Allen P, Modinos G, Hubl D, et al. Neuroimaging auditory 
hallucinations in schizophrenia: from neuroanatomy to neu-
rochemistry and beyond. Schizophr Bull. 2012;38:695–703.
 37. So SH, Peters ER, Swendsen J, Garety PA, Kapur S. 
Changes in delusions in the early phase of  antipsychotic 
treatment - an experience sampling study. Psychiatry Res. 
2014;215:568–573.
 38. Thomas N, Hayward M, Peters ER, et  al. Psychological 
therapies for auditory hallucinations (voices): current sta-
tus and key directions for future research. Schizophr Bull. 
2014;40:S202–S212.
 39. Trower P, Birchwood M, Meaden A, Byrne S, Nelson A, 
Ross K. Cognitive therapy for command hallucinations: ran-
domised controlled trial. Br J Psychiatry. 2004;184:312–320.
 40. Meaden A, Keen N, Aston R, Barton K, Bucci S. Cognitive 
Therapy for Command Hallucinations. London, UK: 
Routledge; 2013.
 41. Chadwick P, Birchwood M. The omnipotence of voices. 
A  cognitive approach to auditory hallucinations. Br J 
Psychiatry. 1994;164:190–201.
 42. Corstens D, McCarthy-Jones S, Waddingham R, Thomas N. 
Emerging perspectives from the Hearing Voices Movement: 
implications for research and practice. Schizophr Bull. 
2014;40:S285–S294.
 43. Chadwick P, Birchwood M, Trower P. Cognitive Therapy for 
Delusions, Voices and Paranoia. Chichester, UK: Wiley; 1996.
 44. Escher S, Romme M. The Hearing Voices Movement. In: 
Blom JD, Sommer IEC, eds. Hallucinations. New York, NY: 
Springer; 2012:385–393.
 45. Scott J, Welham J, Martin G, et al. Demographic correlates of 
psychotic-like experiences in young Australian adults. Acta 
Psychiatr Scand. 2008;118:230–237.
 46. Kay SR, Fiszbein A, Opler LA. The positive and negative 
syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 
1987;13:261–276.
 47. Chadwick P, Hember M, Symes J, Peters E, Kuipers E, Dagnan 
D. Responding mindfully to unpleasant thoughts and images: 
reliability and validity of the Southampton mindfulness ques-
tionnaire (SMQ). Br J Clin Psychol. 2008;47:451–455.
 at W
orld Trade Institute on D
ecem
ber 18, 2014
http://schizophreniabulletin.oxfordjournals.org/
D
ow
nloaded from
 
